COCRYSTAL PHARMA INC (COCP)
US19188J4094 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 26.35M | 37.10M | 58.70M | 33.00M | 7.40M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 890.00K | 700.00K | 0.00 | 600.00K | 600.00K | |||
| Other Current Assets | 1.85M | 2.30M | 700.00K | 500.00K | 300.00K | |||
| Total Current Assets | 29.09M | 40.20M | 59.30M | 34.00M | 8.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.12M | 600.00K | 900.00K | 1.10M | 1.10M | |||
| Investments And Advances | 46.00K | 0.00 | 0.00 | 0.00 | 100.00K | |||
| Goodwill | N/A | 0.00 | 19.10M | 19.10M | 19.10M | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 2.17M | 600.00K | 20.10M | 20.20M | 20.20M | |||
| TOTAL ASSETS | 31.26M | 40.80M | 79.40M | 54.20M | 28.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K | |||
| Accrued Expenses | 2.04M | 600.00K | 900.00K | 600.00K | 700.00K | |||
| Accounts Payable | 1.22M | 600.00K | 600.00K | 700.00K | 1.50M | |||
| Other Current Liabilities | N/A | 0.00 | 0.00 | 100.00K | 0.00 | |||
| Total Current Liabilities | 3.26M | 1.20M | 1.50M | 1.40M | 2.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 1.61M | 100.00K | 300.00K | 300.00K | 500.00K | |||
| Total Non-Current Liabilities | 1.61M | 100.00K | 300.00K | 300.00K | 500.00K | |||
| TOTAL LIABILITIES | 4.88M | 1.30M | 1.80M | 1.70M | 2.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -315.91M | -297.90M | -259.10M | -244.90M | -235.30M | |||
| Additional Paid In Capital | 342.29M | 337.50M | 336.50M | 297.30M | 260.90M | |||
| Common Shares | 10.00K | 0.00 | 100.00K | 100.00K | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 10.17M | 8.10M | 8.10M | 5.90M | 2.90M | |||
| Tangible Book Value per Share | 2.59 | 4.89 | 7.21 | 5.66 | 2.28 | |||
| Total Shareholders' Equity | 26.38M | 39.60M | 77.50M | 52.50M | 25.70M | |||
| TOTAL LIABILITIES AND EQUITY | 31.26M | 40.80M | 79.40M | 54.20M | 28.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 8.92 | 33.50 | 39.53 | 24.29 | 3.61 | |||
| Return On Assets (ROA) | -57.53% | -95.20% | -17.87% | -17.80% | -169.02% | |||
| Return On Equity (ROE) | -68.16% | -98.08% | -18.31% | -18.38% | -187.43% | |||
All data in USD